Functional roles of the interaction of APP and lipoprotein receptors

Theresa Pohlkamp, Catherine R. Wasser, Joachim Herz

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

The biological fates of the key initiator of Alzheimer’s disease (AD), the amyloid precursor protein (APP), and a family of lipoprotein receptors, the low-density lipoprotein (LDL) receptor-related proteins (LRPs) and their molecular roles in the neurodegenerative disease process are inseparably interwoven. Not only does APP bind tightly to the extracellular domains (ECDs) of several members of the LRP group, their intracellular portions are also connected through scaffolds like the one established by FE65 proteins and through interactions with adaptor proteins such as X11/Mint and Dab1. Moreover, the ECDs of APP and LRPs share common ligands, most notably Reelin, a regulator of neuronal migration during embryonic development and modulator of synaptic transmission in the adult brain, and Agrin, another signaling protein which is essential for the formation and maintenance of the neuromuscular junction (NMJ) and which likely also has critical, though at this time less well defined, roles for the regulation of central synapses. Furthermore, the major independent risk factors for AD, Apolipoprotein (Apo) E and ApoJ/Clusterin, are lipoprotein ligands for LRPs. Receptors and ligands mutually influence their intracellular trafficking and thereby the functions and abilities of neurons and the blood-brain-barrier to turn over and remove the pathological product of APP, the amyloid-b peptide. This article will review and summarize the molecular mechanisms that are shared by APP and LRPs and discuss their relative contributions to AD.

Original languageEnglish (US)
Article number54
JournalFrontiers in Molecular Neuroscience
Volume10
DOIs
StatePublished - Mar 1 2017

Fingerprint

LDL-Receptor Related Proteins
Lipoprotein Receptors
Amyloid beta-Protein Precursor
Alzheimer Disease
Ligands
Agrin
Clusterin
Mentha
Proteins
Aptitude
Neuromuscular Junction
LDL Receptors
Apolipoproteins E
Blood-Brain Barrier
Amyloid
Synaptic Transmission
Neurodegenerative Diseases
Synapses
Lipoproteins
Embryonic Development

Keywords

  • Amyloid beta
  • APOE
  • Glutamate receptors
  • LDL receptor gene family
  • LRP
  • Neuromuscular junction
  • Synapse
  • Trafficking

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience

Cite this

Functional roles of the interaction of APP and lipoprotein receptors. / Pohlkamp, Theresa; Wasser, Catherine R.; Herz, Joachim.

In: Frontiers in Molecular Neuroscience, Vol. 10, 54, 01.03.2017.

Research output: Contribution to journalReview article

@article{187db395855942ebada1b6aa70441f94,
title = "Functional roles of the interaction of APP and lipoprotein receptors",
abstract = "The biological fates of the key initiator of Alzheimer’s disease (AD), the amyloid precursor protein (APP), and a family of lipoprotein receptors, the low-density lipoprotein (LDL) receptor-related proteins (LRPs) and their molecular roles in the neurodegenerative disease process are inseparably interwoven. Not only does APP bind tightly to the extracellular domains (ECDs) of several members of the LRP group, their intracellular portions are also connected through scaffolds like the one established by FE65 proteins and through interactions with adaptor proteins such as X11/Mint and Dab1. Moreover, the ECDs of APP and LRPs share common ligands, most notably Reelin, a regulator of neuronal migration during embryonic development and modulator of synaptic transmission in the adult brain, and Agrin, another signaling protein which is essential for the formation and maintenance of the neuromuscular junction (NMJ) and which likely also has critical, though at this time less well defined, roles for the regulation of central synapses. Furthermore, the major independent risk factors for AD, Apolipoprotein (Apo) E and ApoJ/Clusterin, are lipoprotein ligands for LRPs. Receptors and ligands mutually influence their intracellular trafficking and thereby the functions and abilities of neurons and the blood-brain-barrier to turn over and remove the pathological product of APP, the amyloid-b peptide. This article will review and summarize the molecular mechanisms that are shared by APP and LRPs and discuss their relative contributions to AD.",
keywords = "Amyloid beta, APOE, Glutamate receptors, LDL receptor gene family, LRP, Neuromuscular junction, Synapse, Trafficking",
author = "Theresa Pohlkamp and Wasser, {Catherine R.} and Joachim Herz",
year = "2017",
month = "3",
day = "1",
doi = "10.3389/fnmol.2017.00054",
language = "English (US)",
volume = "10",
journal = "Frontiers in Molecular Neuroscience",
issn = "1662-5099",
publisher = "Frontiers Research Foundation",

}

TY - JOUR

T1 - Functional roles of the interaction of APP and lipoprotein receptors

AU - Pohlkamp, Theresa

AU - Wasser, Catherine R.

AU - Herz, Joachim

PY - 2017/3/1

Y1 - 2017/3/1

N2 - The biological fates of the key initiator of Alzheimer’s disease (AD), the amyloid precursor protein (APP), and a family of lipoprotein receptors, the low-density lipoprotein (LDL) receptor-related proteins (LRPs) and their molecular roles in the neurodegenerative disease process are inseparably interwoven. Not only does APP bind tightly to the extracellular domains (ECDs) of several members of the LRP group, their intracellular portions are also connected through scaffolds like the one established by FE65 proteins and through interactions with adaptor proteins such as X11/Mint and Dab1. Moreover, the ECDs of APP and LRPs share common ligands, most notably Reelin, a regulator of neuronal migration during embryonic development and modulator of synaptic transmission in the adult brain, and Agrin, another signaling protein which is essential for the formation and maintenance of the neuromuscular junction (NMJ) and which likely also has critical, though at this time less well defined, roles for the regulation of central synapses. Furthermore, the major independent risk factors for AD, Apolipoprotein (Apo) E and ApoJ/Clusterin, are lipoprotein ligands for LRPs. Receptors and ligands mutually influence their intracellular trafficking and thereby the functions and abilities of neurons and the blood-brain-barrier to turn over and remove the pathological product of APP, the amyloid-b peptide. This article will review and summarize the molecular mechanisms that are shared by APP and LRPs and discuss their relative contributions to AD.

AB - The biological fates of the key initiator of Alzheimer’s disease (AD), the amyloid precursor protein (APP), and a family of lipoprotein receptors, the low-density lipoprotein (LDL) receptor-related proteins (LRPs) and their molecular roles in the neurodegenerative disease process are inseparably interwoven. Not only does APP bind tightly to the extracellular domains (ECDs) of several members of the LRP group, their intracellular portions are also connected through scaffolds like the one established by FE65 proteins and through interactions with adaptor proteins such as X11/Mint and Dab1. Moreover, the ECDs of APP and LRPs share common ligands, most notably Reelin, a regulator of neuronal migration during embryonic development and modulator of synaptic transmission in the adult brain, and Agrin, another signaling protein which is essential for the formation and maintenance of the neuromuscular junction (NMJ) and which likely also has critical, though at this time less well defined, roles for the regulation of central synapses. Furthermore, the major independent risk factors for AD, Apolipoprotein (Apo) E and ApoJ/Clusterin, are lipoprotein ligands for LRPs. Receptors and ligands mutually influence their intracellular trafficking and thereby the functions and abilities of neurons and the blood-brain-barrier to turn over and remove the pathological product of APP, the amyloid-b peptide. This article will review and summarize the molecular mechanisms that are shared by APP and LRPs and discuss their relative contributions to AD.

KW - Amyloid beta

KW - APOE

KW - Glutamate receptors

KW - LDL receptor gene family

KW - LRP

KW - Neuromuscular junction

KW - Synapse

KW - Trafficking

UR - http://www.scopus.com/inward/record.url?scp=85019222907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019222907&partnerID=8YFLogxK

U2 - 10.3389/fnmol.2017.00054

DO - 10.3389/fnmol.2017.00054

M3 - Review article

C2 - 28298885

AN - SCOPUS:85019222907

VL - 10

JO - Frontiers in Molecular Neuroscience

JF - Frontiers in Molecular Neuroscience

SN - 1662-5099

M1 - 54

ER -